SharePost Content Read More Yahoo Finance #finance Post navigation H.C. Wainwright Reiterates a Buy Rating on Beam Therapeutics (BEAM) With an $80 PT Morgan Stanley Raises PT on Apellis Pharmaceuticals (APLS) to $26, Keeps a Hold Rating